×
About 1,535 results

ALLMedicine™ Hypersensitivity Pneumonitis Center

Research & Reviews  761 results

Transbronchial Biopsy and Cryobiopsy in the Diagnosis of Hypersensitivity Pneumonitis a...
https://doi.org/10.1513/AnnalsATS.202005-421OC
Annals of the American Thoracic Society; Chami HA, Diaz-Mendoza J et. al.

Aug 18th, 2020 - Hypersensitivity Pneumonitis (HP) is an interstitial lung disease (ILD) whose diagnosis is based on clinical, radiological, and pathological findings. The evidence supporting transbronchial forceps lung biopsy (TBBx) and transbronchial lung cryobi...

Hypersensitivity pneumonitis: the first diagnostic guidelines.
https://doi.org/10.1016/S2213-2600(20)30359-3
The Lancet. Respiratory Medicine; Tzilas V, Tzouvelekis A et. al.

Aug 16th, 2020 - Hypersensitivity pneumonitis: the first diagnostic guidelines.|2020|Tzilas V,Tzouvelekis A,Bouros D,|

Questionnaires or Serum IgG Testing in the Diagnosis of Hypersensitivity Pneumonitis am...
https://doi.org/10.1513/AnnalsATS.202005-419OC
Annals of the American Thoracic Society; Jenkins AR, Chua A et. al.

Aug 11th, 2020 - Hypersensitivity Pneumonitis (HP) results from exposure to a variety of stimuli, which are challenging to identify. Questionnaires and serum IgG testing are methods to identify potentially causative exposures. To perform a systematic review to det...

Hypersensitivity pneumonitis.
https://doi.org/10.1038/s41572-020-0191-z
Nature Reviews. Disease Primers; Costabel U, Miyazaki Y et. al.

Aug 8th, 2020 - Hypersensitivity pneumonitis (HP) is a complex syndrome caused by the inhalation of a variety of antigens in susceptible and sensitized individuals. These antigens are found in the environment, mostly derived from bird proteins and fungi. The prev...

Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis amo...
https://doi.org/10.1513/AnnalsATS.202005-420OC
Annals of the American Thoracic Society; Patolia S, Tamae Kakazu M et. al.

Aug 5th, 2020 - Hypersensitivity Pneumonitis (HP) is an interstitial lung disease (ILD) characterized by inflammation and/or fibrosis in response to an inhalational exposure. To determine the value of bronchoalveolar lavage (BAL) fluid lymphocyte cellular analysi...

see more →

Clinicaltrials.gov  765 results

Transbronchial Biopsy and Cryobiopsy in the Diagnosis of Hypersensitivity Pneumonitis a...
https://doi.org/10.1513/AnnalsATS.202005-421OC
Annals of the American Thoracic Society; Chami HA, Diaz-Mendoza J et. al.

Aug 18th, 2020 - Hypersensitivity Pneumonitis (HP) is an interstitial lung disease (ILD) whose diagnosis is based on clinical, radiological, and pathological findings. The evidence supporting transbronchial forceps lung biopsy (TBBx) and transbronchial lung cryobi...

Hypersensitivity pneumonitis: the first diagnostic guidelines.
https://doi.org/10.1016/S2213-2600(20)30359-3
The Lancet. Respiratory Medicine; Tzilas V, Tzouvelekis A et. al.

Aug 16th, 2020 - Hypersensitivity pneumonitis: the first diagnostic guidelines.|2020|Tzilas V,Tzouvelekis A,Bouros D,|

Questionnaires or Serum IgG Testing in the Diagnosis of Hypersensitivity Pneumonitis am...
https://doi.org/10.1513/AnnalsATS.202005-419OC
Annals of the American Thoracic Society; Jenkins AR, Chua A et. al.

Aug 11th, 2020 - Hypersensitivity Pneumonitis (HP) results from exposure to a variety of stimuli, which are challenging to identify. Questionnaires and serum IgG testing are methods to identify potentially causative exposures. To perform a systematic review to det...

Hypersensitivity pneumonitis.
https://doi.org/10.1038/s41572-020-0191-z
Nature Reviews. Disease Primers; Costabel U, Miyazaki Y et. al.

Aug 8th, 2020 - Hypersensitivity pneumonitis (HP) is a complex syndrome caused by the inhalation of a variety of antigens in susceptible and sensitized individuals. These antigens are found in the environment, mostly derived from bird proteins and fungi. The prev...

Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis amo...
https://doi.org/10.1513/AnnalsATS.202005-420OC
Annals of the American Thoracic Society; Patolia S, Tamae Kakazu M et. al.

Aug 5th, 2020 - Hypersensitivity Pneumonitis (HP) is an interstitial lung disease (ILD) characterized by inflammation and/or fibrosis in response to an inhalational exposure. To determine the value of bronchoalveolar lavage (BAL) fluid lymphocyte cellular analysi...

see more →

News  9 results

CT honeycombing key to hypersensitivity pneumonitis prognosis
https://www.mdedge.com/fedprac/article/198490/pulmonology/ct-honeycombing-key-hypersensitivity-pneumonitis-prognosis
Andrew D. Bowser

Apr 9th, 2019 - In patients with hypersensitivity pneumonitis, presence of radiologic honeycombing suggests a poor prognosis in line with what might be expected with idiopathic pulmonary fibrosis, results of a recent study suggest. When radiologic honeycombing wa.

CT scan honeycombing key to hypersensitivity pneumonitis prognosis
https://www.mdedge.com/internalmedicine/article/198490/pulmonology/ct-scan-honeycombing-key-hypersensitivity-pneumonitis?channel=39313
Andrew D. Bowser

Apr 9th, 2019 - In patients with hypersensitivity pneumonitis, presence of radiologic honeycombing suggests a poor prognosis in line with what might be expected with idiopathic pulmonary fibrosis, results of a recent study suggest. When radiologic honeycombing wa.

FDA recommends voluntary recall of Limbrel
https://www.mdedge.com/familymedicine/article/153691/osteoarthritis/fda-recommends-voluntary-recall-limbrel
Rheumatology News; Dan Watson

Dec 6th, 2017 - The Food and Drug Administration announced on Dec. 4 that it recommends the voluntary recall of Limbrel, a medical food product in capsule form that is currently marketed to “manage the metabolic processes associated with osteoarthritis.

The rise and fall of treatment trials in group 3 pulmonary hypertension: Where do we go from here?
https://www.mdedge.com/chestphysician/article/153652/pulmonology/rise-and-fall-treatment-trials-group-3-pulmonary/page/0/1

Dec 6th, 2017 - To be included in RISE-IIP, patients were required to have an idiopathic interstitial pneumonia, PH confirmed by RHC with a mPAP ≥ 25 mm Hg, World Health Organization Functional Class 2-4 symptoms, and a forced vital capacity (FVC) ≥ 45% predicted.

Primus Announces a Voluntary Nationwide Recall of All Lots Within Expiry of Prescription Medical Food Limbrel® Due to Rare But Serious and Reversible Adverse Events While Seeking FDA's Cooperation ...
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/primus-announces-voluntary-nationwide-recall-all-lots-within-expiry-prescription-medical-food

Summary Company Announcement Date: January 25, 2018 FDA Publish Date: January 29, 2018 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to adverse event reports of elevated liver function tests or acute hypersensitivity p...

see more →